EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
31/07/2026
Voltar para busca
Dado oficial do USPTO
ENACT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
01/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
05/06/2019
Data de registro
08/12/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/12/2020
Última transação
01/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Wilmington, DE, US
Examinador
MORENO, PAUL A
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
INCYTE HOLDINGS CORPORATION
MorphoSys AG
Representantes
Keith Toms, Esq. McCarter & English, LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer; vaccine preparations for use in connection with cancer and oncology; antibodies sold as an ingredient of pharmaceuticals for the treatment of cancer; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines for use in connection with cancer and oncology; biological preparations for human medical diagnostics and analysis for use in the treatment of cancer; medical diagnostic reagents for use in connection with cancer and oncology; clinical medical reagents for use in connection with cancer and oncology; biological preparations for medical and veterinary purposes in connection with the treatment of cancer
Classe 42
Research and development in the pharmaceutical and biotechnology fields in connection with cancer and oncology; research and development of medicines in the fields of cancer and oncology; scientific and technological services and research and design services in the fields of cancer and oncology; biological researchclinical research and medical research in the fields of cancer and oncology; chemical and biochemical analysis services in the fields of cancer and oncology; laboratory research in the fields of analytical chemistrybiochemistrymedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biology in connection with cancer and oncology; clinical research in the fields of cancer and oncology; providing medical and scientific research information in the field of pharmaceuticals in connection with cancer and oncology; Research and development services in the field of antibodies for use in connection with cancer and oncology
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/07/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31/07/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31/07/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/07/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
31/07/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/06/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/06/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/05/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
03/11/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
27/10/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
14/09/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
14/09/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/05/2020
PUBO
PUBLISHED FOR OPPOSITION
19/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2020
ALIE
ASSIGNED TO LIE
09/04/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/04/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
17/03/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
17/03/2020
CNSI
SUSPENSION INQUIRY WRITTEN
17/03/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/09/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/09/2019
CNSL
SUSPENSION LETTER WRITTEN
03/09/2019
DOCK
ASSIGNED TO EXAMINER
26/08/2019
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
21/08/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
21/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/06/2019
NWAP
NEW APPLICATION ENTERED
08/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENACT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.